BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15222457)

  • 1. On the therapeutic action of SSRI medications.
    Levine FJ
    J Am Psychoanal Assoc; 2004; 52(2):492-3; author reply 493-8. PubMed ID: 15222457
    [No Abstract]   [Full Text] [Related]  

  • 2. On the therapeutic action of SSRI medications.
    Ostow M
    J Am Psychoanal Assoc; 2004; 52(2):486-9; author reply 493-8. PubMed ID: 15222454
    [No Abstract]   [Full Text] [Related]  

  • 3. On the therapeutic action of SSRI medications.
    Sandberg LS
    J Am Psychoanal Assoc; 2004; 52(2):490-1; author reply 493-8. PubMed ID: 15222456
    [No Abstract]   [Full Text] [Related]  

  • 4. On the therapeutic action of SSRI medications.
    Levinson MH
    J Am Psychoanal Assoc; 2004; 52(2):483-6; author reply 493-8. PubMed ID: 15222453
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
    Benkert O; Wetzel H; Szegedi A
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():3-14. PubMed ID: 8254151
    [No Abstract]   [Full Text] [Related]  

  • 6. On the therapeutic action of SSRI medications.
    Wolpert E
    J Am Psychoanal Assoc; 2004; 52(2):489; author reply 493-8. PubMed ID: 15222455
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of selective serotonin reuptake inhibitor (SSRI) in the treatment of depression].
    Semba J
    Nihon Yakurigaku Zasshi; 2000 Aug; 116(2):79-84. PubMed ID: 10976459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin dysfunction disorders: a behavioral neurochemistry perspective.
    Petty F; Davis LL; Kabel D; Kramer GL
    J Clin Psychiatry; 1996; 57 Suppl 8():11-6. PubMed ID: 8698675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selective serotonin reuptake inhibitor(SSRI)].
    Motohashi N
    Nihon Rinsho; 2001 Aug; 59(8):1519-22. PubMed ID: 11519151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence.
    Hammerness PG; Vivas FM; Geller DA
    J Pediatr; 2006 Feb; 148(2):158-65. PubMed ID: 16492422
    [No Abstract]   [Full Text] [Related]  

  • 11. A psychoanalytic hypothesis concerning the therapeutic action of SSRI medications.
    Gottlieb R
    J Am Psychoanal Assoc; 2002; 50(3):969-71. PubMed ID: 12434878
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL; Pigott TA
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological basis of anxiety disorders and serotonergic anxiolytics].
    Inoue T; Izumi T; Li XB; Huang JZ; Kitaichi Y; Nakagawa S; Koyama T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):125-31. PubMed ID: 15291241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs to Treat Anxiety Disorders and Obsessive Compulsive Disorder (OCD).
    J Psychosoc Nurs Ment Health Serv; 2024 May; 62(5):5-6. PubMed ID: 38709092
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine.
    den Boer JA; Westenberg HG; De Leeuw AS; van Vliet IM
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():47-52. PubMed ID: 7622824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy.
    De Berardis D; Serroni N; Campanella D; Olivieri L; Moschetta FS; Conti CM; Conti P; Di Giannantonio M
    J Clin Psychopharmacol; 2012 Apr; 32(2):289-90. PubMed ID: 22388158
    [No Abstract]   [Full Text] [Related]  

  • 17. Paroxetine and its uses in psychiatry.
    Bell C; Nutt D
    Hosp Med; 1999 May; 60(5):353-6. PubMed ID: 10396411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-release fluvoxamine (Luvox CR).
    Med Lett Drugs Ther; 2008 Jun; 50(1289):50-1. PubMed ID: 18583947
    [No Abstract]   [Full Text] [Related]  

  • 19. SSRI adverse events: how to monitor and manage.
    Murphy TK; Segarra A; Storch EA; Goodman WK
    Int Rev Psychiatry; 2008 Apr; 20(2):203-8. PubMed ID: 18386213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive compulsive disorder is not an anxiety disorder.
    Montgomery SA
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():57-62. PubMed ID: 8254154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.